1. Home
  2. TYRA vs SHAK Comparison

TYRA vs SHAK Comparison

Compare TYRA & SHAK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Tyra Biosciences Inc.

TYRA

Tyra Biosciences Inc.

HOLD

Current Price

$33.74

Market Cap

2.0B

Sector

Health Care

ML Signal

HOLD

Logo Shake Shack Inc.

SHAK

Shake Shack Inc.

HOLD

Current Price

$62.97

Market Cap

2.4B

ML Signal

HOLD

Company Overview

Basic Information
Metric
TYRA
SHAK
Founded
2018
2004
Country
United States
United States
Employees
N/A
13873
Industry
Biotechnology: Pharmaceutical Preparations
Restaurants
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
2.0B
2.4B
IPO Year
2021
2014

Fundamental Metrics

Financial Performance
Metric
TYRA
SHAK
Price
$33.74
$62.97
Analyst Decision
Strong Buy
Buy
Analyst Count
11
26
Target Price
$47.50
$117.29
AVG Volume (30 Days)
749.1K
2.3M
Earning Date
05-06-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
354.17
EPS
N/A
N/A
Revenue
N/A
$1,445,306,000.00
Revenue This Year
N/A
$16.58
Revenue Next Year
N/A
$15.07
P/E Ratio
N/A
N/A
Revenue Growth
N/A
15.38
52 Week Low
$8.75
$59.49
52 Week High
$40.65
$142.23

Technical Indicators

Market Signals
Indicator
TYRA
SHAK
Relative Strength Index (RSI) 43.61 28.55
Support Level $33.29 N/A
Resistance Level $33.99 $94.90
Average True Range (ATR) 1.98 3.57
MACD -0.02 -2.27
Stochastic Oscillator 30.44 8.00

Price Performance

Historical Comparison
TYRA
SHAK

About TYRA Tyra Biosciences Inc.

Tyra Biosciences Inc is a clinical-stage biotechnology company focused on developing next-generation precision medicines for large opportunities in targeted oncology and genetically defined conditions, harnessing the power of Fibroblast Growth Factor Receptor (FGFR) biology. The company's in-house precision medicine platform, SNAP, enables rapid and precise drug design through iterative molecular SNAPshots that help to design and predict which product candidates may demonstrate the highest potency, selectivity, and tolerability in the clinic. The various drug candidates in the company's product pipeline are FGFR3, FGFR4/3, and FGFR1/2/3: three clinical-stage, novel small molecules designed to overcome the toxicity and resistance liabilities of first-generation pan-FGFR inhibitors.

About SHAK Shake Shack Inc.

Shake Shack Inc is a roadside burger stand. It serves a classic American menu of premium burgers, hot dogs, crispy chicken, frozen custard, crinkle-cut fries, shakes, beer, wine, and more. The company's burgers are made with a whole-muscle blend of all-natural, hormone and antibiotic-free Angus beef, ground fresh daily, cooked to order, and served on a non-genetically modified organism (GMO) potato bun. Its menu focuses on food and beverages, crafted from a range of classic American foods. The company serves draft Root Beer, seasonal freshly-squeezed lemonade, organic fresh-brewed iced tea, cold brew coffee, organic apple juice, and Shack20 bottled water. Geographically, the company generates the majority of its revenue from the United States.

Share on Social Networks: